Showing Latest Articles
Valproate for the treatment of medication-induced impulse-control disorders in three patients with Parkinsons disease
Parkinsonism & Related Disorders, 06/08/2011
Clinical Article
Hicks CW et al. – Based on these encouraging preliminary observations, future controlled clinical trials investigating the efficacy of valproate for Impulse–control disorders in Parkinson disease are recommended.
- Impulse–control disorders are becoming more commonly recognized in the Parkinson disease population.
- To date, there are no definitive methods of treating dopamine dysregulation syndromes in Parkinson disease patients.
- The authors sought to uncover an effective treatment option for future study.
- Series of 3 Parkinsons disease patients with Impulse–control disorders who were effectively treated with valproate are reported.
